Strategic Acquisition GBL has a history of acquisitions and is now part of larger health and sterilization networks (Nelson Labs, Sotera Health). This presents cross-sell opportunities for integrated sterilization validation, analytical testing, and regulatory support across a broader customer base.

Regulatory Footprint With FDA registration, ISO 17025 accreditation, and active engagement with regulatory bodies and trade organizations, Gibraltar Laboratories can offer compliant, high-assurance testing services to biopharma, medical device, and cosmetic manufacturers seeking certified partners.

Quality and Capacity A 45+ year track record, senior PhD or MS leadership across departments, and multi-site 48,000 sq ft footprint indicate reliability and scalable capacity for large or rising client projects in sterilization and analytical testing.

Industry Reach Serving pharma, medical devices, orthopedics, tissue banks, chemicals, and cosmetics, Gibraltar touches diverse segments, enabling targeted outreach to risk-heavy sectors requiring robust QC, regulatory compliance, and rapid turnaround.

Growth Readiness Rapid growth narrative, family-owned culture emphasizing quality and positive work environment positions Gibraltar as a strategic partner for clients seeking dependable service levels, continuous improvement, and strong client relationships during expansion.